MONOCYCLIC PYRIDINE DERIVATIVE

The present invention discloses a compound represented by the following formula (IA) or a pharmaceutically acceptable salt thereof: wherein n represents 0 to 2; A represents an arylene group or a heteroarylene group; G represents a single bond, an oxygen atom or -CH 2 -; E represents a nitrogen-cont...

Full description

Saved in:
Bibliographic Details
Main Authors FUNASAKA, SETSUO, OKADA, TOSHIMI, TANAKA, KEIGO, OHASHI, ISAO, NAGAO, SATOSHI, YAMANE, YOSHINOBU, NAKATANI, YUSUKE, KAROJI, YUKI
Format Patent
LanguageEnglish
Serbian
Published 31.10.2017
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention discloses a compound represented by the following formula (IA) or a pharmaceutically acceptable salt thereof: wherein n represents 0 to 2; A represents an arylene group or a heteroarylene group; G represents a single bond, an oxygen atom or -CH 2 -; E represents a nitrogen-containing non-aromatic heterocycle; R 1 represents an alkoxy group, an alkoxy alkoxy group or the like; R 2 represents a hydrogen atom, a halogen atom, a hydroxyl group, an alkyl group, a hydroxy alkyl group, a nitrogen-containing non-aromatic heterocyclic group or the like; R 3 represents a hydrogen atom, an alkyl group, an alkoxy group or the like; and R 4 represents a C 1-6 alkyl group, with the proviso that when E represents an azetidine ring and R 2 or R 3 is present on a nitrogen atom on the azetidine ring, the R 2 or R 3 does not represent a hydrogen atom.
Bibliography:Application Number: RS2017P000596